# PSTB100 Study in Healthy Adult Subjects

> **NCT07702279** · PHASE1 · RECRUITING · sponsor: **Prospect Therapeutics (Nanjing) Limited** · enrollment: 68 (estimated)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** PSTB100 tablets
- **DRUG:** PSTB100 tablets

## Key facts

- **NCT ID:** NCT07702279
- **Lead sponsor:** Prospect Therapeutics (Nanjing) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2027-06-12
- **Final completion:** 2027-09-06
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07702279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07702279, "PSTB100 Study in Healthy Adult Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07702279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*